XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Distributions in Excess of Accumulated Net Income
Accumulated Comprehensive Income
Balance beginning of period (in shares) at Dec. 31, 2022   67,472,553      
Balance beginning of period at Dec. 31, 2022 $ 1,603,909 $ 67 $ 5,456,968 $ (3,879,847) $ 26,721
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 1,133     1,133  
Unrealized gain (loss) on derivatives (3,317)       (3,317)
Reclassification to interest expense, net (2,892)       (2,892)
Distributions declared (14,548)     (14,548)  
Stock-based compensation, net (in shares)   36,088      
Stock-based compensation, net 2,120 $ 1 2,119    
Balance end of period (in shares) at Mar. 31, 2023   67,508,641      
Balance end of period at Mar. 31, 2023 1,586,405 $ 68 5,459,087 (3,893,262) 20,512
Balance beginning of period (in shares) at Dec. 31, 2022   67,472,553      
Balance beginning of period at Dec. 31, 2022 1,603,909 $ 67 5,456,968 (3,879,847) 26,721
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 2,379        
Unrealized gain (loss) on derivatives 13,496        
Reclassification to interest expense, net (11,089)        
Balance end of period (in shares) at Sep. 30, 2023   67,531,335      
Balance end of period at Sep. 30, 2023 1,571,532 $ 68 5,463,458 (3,921,122) 29,128
Balance beginning of period (in shares) at Mar. 31, 2023   67,508,641      
Balance beginning of period at Mar. 31, 2023 1,586,405 $ 68 5,459,087 (3,893,262) 20,512
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 2,068     2,068  
Unrealized gain (loss) on derivatives 10,835       10,835
Reclassification to interest expense, net (3,984)       (3,984)
Distributions declared (14,553)     (14,553)  
Stock-based compensation, net (in shares)   22,694      
Stock-based compensation, net 2,166   2,166    
Balance end of period (in shares) at Jun. 30, 2023   67,531,335      
Balance end of period at Jun. 30, 2023 1,582,937 $ 68 5,461,253 (3,905,747) 27,363
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (822)     (822)  
Unrealized gain (loss) on derivatives 5,978       5,978
Reclassification to interest expense, net (4,213)       (4,213)
Distributions declared (14,553)     (14,553)  
Stock-based compensation, net 2,205   2,205    
Balance end of period (in shares) at Sep. 30, 2023   67,531,335      
Balance end of period at Sep. 30, 2023 $ 1,571,532 $ 68 5,463,458 (3,921,122) 29,128
Balance beginning of period (in shares) at Dec. 31, 2023 67,807,831 67,807,831      
Balance beginning of period at Dec. 31, 2023 $ 1,554,044 $ 68 5,468,728 (3,932,826) 18,074
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 2,900     2,900  
Unrealized gain (loss) on derivatives 7,319       7,319
Reclassification to interest expense, net (3,317)       (3,317)
Distributions declared (15,360)     (15,360)  
Stock-based compensation, net (in shares)   66,697      
Stock-based compensation, net 2,463   2,463    
Balance end of period (in shares) at Mar. 31, 2024   67,874,528      
Balance end of period at Mar. 31, 2024 $ 1,548,049 $ 68 5,471,191 (3,945,286) 22,076
Balance beginning of period (in shares) at Dec. 31, 2023 67,807,831 67,807,831      
Balance beginning of period at Dec. 31, 2023 $ 1,554,044 $ 68 5,468,728 (3,932,826) 18,074
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 3,859        
Unrealized gain (loss) on derivatives 2,560        
Reclassification to interest expense, net $ (9,946)        
Balance end of period (in shares) at Sep. 30, 2024 77,130,431 77,130,431      
Balance end of period at Sep. 30, 2024 $ 1,755,205 $ 77 5,721,592 (3,977,152) 10,688
Balance beginning of period (in shares) at Mar. 31, 2024   67,874,528      
Balance beginning of period at Mar. 31, 2024 1,548,049 $ 68 5,471,191 (3,945,286) 22,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 1,498     1,498  
Unrealized gain (loss) on derivatives 2,386       2,386
Reclassification to interest expense, net (3,314)       (3,314)
Distributions declared (15,370)     (15,370)  
Stock-based compensation, net (in shares)   42,600      
Stock-based compensation, net 2,324   2,324    
Balance end of period (in shares) at Jun. 30, 2024   67,917,128      
Balance end of period at Jun. 30, 2024 1,535,573 $ 68 5,473,515 (3,959,158) 21,148
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (539)     (539)  
Unrealized gain (loss) on derivatives (7,145)       (7,145)
Reclassification to interest expense, net (3,315)       (3,315)
Distributions declared (17,455)     (17,455)  
Issuance of common stock, net (in shares)   9,200,000      
Issuance of common stock, net 245,843 $ 9 245,834    
Stock-based compensation, net (in shares)   13,303      
Stock-based compensation, net $ 2,243   2,243    
Balance end of period (in shares) at Sep. 30, 2024 77,130,431 77,130,431      
Balance end of period at Sep. 30, 2024 $ 1,755,205 $ 77 $ 5,721,592 $ (3,977,152) $ 10,688